About the Company
welcome to our company page and thank you for your interest in aptinyx inc. aptinyx is a biopharmaceutical company discovering and developing innovative therapies for challenging disorders of the brain and nervous system. aptinyx has a proven platform for discovering proprietary compounds that work through a novel mechanism: modulation of the nmda receptor to enhance pathways involved with nerve cell communication. our goal is to rapidly advance our most promising drug candidates into clinical development for indications with high unmet medical need. at aptinyx, we remain committed and responsive to our employees. we offer an engaging work environment, challenging work assignments, and competitive compensation and benefits. if you are interested in learning more, please visit our website at www.aptinyx.com.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $APTX News
Aptinyx Inc. Common Stock (APTX)
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green highlights the top performing ETF by % change in the past ...
Patrick G Enright's Net Worth
Inc., Aptinyx Inc., Aimmune Therapeutics, Inc., and SEQUENOM INC. Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to ...
Brighter Futures
Moskal and his team are now poised to continue innovating in new disease areas with their spin-off company, Aptinyx Inc., which will move forward with the discovery engine and earlystage programs ...
DaVita (DVA) to Report Q1 Earnings: What's in the Offing?
Aptinyx Inc. APTX has an Earnings ESP of +19.23% and a Zacks Rank of 2. APTX has an estimated growth rate of 42.6% for 2024. You can see the complete list of today’s Zacks #1 Rank stocks here.
Breakthrough study on post-traumatic stress disorder
A UC San Diego-led collaboration of researchers, institutions and databases makes advances on the understanding of the ...
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.34%
The worst performers were Aptinyx Inc (NASDAQ:APTX) which was down 39.00% to 0.06 in late trade, NanoString Technologies Inc (NASDAQ:NSTG) which lost 29.02% to settle at 6.04 and Rigel ...
Netlist, Inc. (NLST)
Netlist, Inc. (PNK:NLST) Q1 2024 Earnings Call Transcript April 25, 2024 Netlist, Inc. misses on earnings expectations. Reported EPS is $-0.07 EPS, expectations were $-0.05. NLST isn’t one of ...
Opioid Withdrawal Syndrome Drug Market to Surge at a CAGR of 4.0% by 2034 | DelveInsight
Leading opioid withdrawal syndrome companies such as DemeRx IB, Inc., atai Life Sciences, MediciNova, BioXcel Therapeutics ...
Inc. 5000 Conference
She spoke at the 2023 Inc. 5000 Conference about the difference between marketing and advertising. At the Inc. 5000 Conference, Howroyd, the first Black woman to build and own a billion-dollar ...
About Inc.com | Everything You Need to Know to Grow and Start Your Business
Inc. is the voice of the American entrepreneur. We inspire, inform, and document the most fascinating people in business: the risk-takers, the innovators, and the ultra-driven go-getters that ...
Tanger Inc. Common Stock (SKT)
The Dividend History page provides a single page to review all of the aggregated Dividend payment information. Visit our Dividend Calendar: Our partner, Quotemedia, provides the upcoming ex ...
Loading the latest forecasts...